SCOTTSDALE, Ariz., July 18, 2018 /PRNewswire-PRWeb/ --áDr. Nikesh Seth has stood at the
Radiofrequency ablation is a relatively new treatment, having only been developed and promoted in the last 30 years. During the procedure, doctors use radio waves to induce an electric current in the affected nerve tissue, heating it and reducing the number of pain signals it transmits to the brain.
"The procedure provides pain relief for six to 12 months on average," Dr. Seth said. "Although, some of my patients have said it helps them for up to two years."
Researchers at the Johns Hopkins University School of Medicine (https://www.hopkinsmedicine.org/news/media/releases/direct_electrical_current_used_to_preferentially_inhibit_pain_transmitting_neurons) concluded that radiofrequency ablation is an effective pain treatment. Using rats and computer models, they found that direct electric current can successfully block pain signals by targeting certain nerves.
Dr. Gene Fridman, an assistant professor at the School of Medicine, said the goal of this research is to take current radiofrequency ablation techniques and move them toward a neural implant model. Neural implants would allow doctors to excite or inhibit a patient's affected neurons, reducing pain or increasing sensitivity.
Currently, no permanent neural implants are available commercially. In recent years, radiofrequency ablation has enjoyed a surge in research and application. An April 2018 report from Transparency Market Research predicts that the market for radiofrequency ablation devices will reach billions of dollars by 2024.
"I am encouraged that my colleagues have begun recognizing the benefits of radiofrequency ablation," Dr. Seth said. "I've recommended radiofrequency ablation to my patients for years because it provides more effective long-term pain management for many various disease states and much safer than opioid use."
Find out more at http://www.nikeshsethmd.com.
SOURCE PRWeb House E-Commerce
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All